Journal
CURRENT DRUG DELIVERY
Volume 12, Issue 5, Pages 524-532Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1567201812666150724094207
Keywords
Heat shock proteins; Hsp70; Intranasal administration; UPS; Toll-like receptors
Categories
Funding
- Russian Scientific Foundation [14-24-00100]
- Russian Science Foundation [14-24-00100] Funding Source: Russian Science Foundation
Ask authors/readers for more resources
Over the last decade, it has become evident that in mammals, including humans, heat shock protein 70 (HSP70), apart from its intracellular localization, is found in extracellular space, where it may execute various protective functions. Furthermore, the upregulation of HSP70 family members can be beneficial in the prevention and treatment of various human neurodegenerative diseases and cancer. Here, we demonstrate that recombinant human HSP70 after intranasal administration can penetrate various brain regions of mice in its native form and subsequently undergo rapid degradation. It was also shown that labeled HSP70 added to culture medium of different human and mouse cell lines enters the cells with strikingly different kinetics, which positively correlates with the basic levels of membrane bound Toll-like receptors (TLR) that are characteristic of these cell lines. HSP70 administration does not significantly modulate the level of TLR expression at the protein or RNA level. The degradation of the introduced recombinant HSP70 after entering the cells is likely proteasome-dependent and varies significantly depending on the cells type and origin. These results should be considered when developing HSP70-based therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available